Cargando…

Human mesenchymal stem cells treatment improved hepatic lesions and reversed gut microbiome disorder in non-alcoholic steatohepatitis

Effective therapies for non-alcoholic steatohepatitis (NASH) are urgently needed. We investigated the effect of human mesenchymal stem cells (hMSCs) on the intestinal flora in NASH treatment. We isolated the hMSCs from the umbilical cords and divided male C57BL/6 mice into three groups, namely, chow...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yang, Zhiyu, Xia, Qiaoyun, Lu, Di, Yue, Han, Zhang, Jianmin, Li, Yalong, Zhang, Bingyong, Li, Xiuling, Cao, Mingbo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals 2020
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7695425/ https://www.ncbi.nlm.nih.gov/pubmed/33168782 http://dx.doi.org/10.18632/aging.103962

Ejemplares similares

Rifaximin Ameliorates Non-alcoholic Steatohepatitis in Mice Through Regulating gut Microbiome-Related Bile Acids
por: Jian, Jie, et al.
Publicado: (2022)

Characterization of Gut Microbiome in Liver Transplant Recipients With Nonalcoholic Steatohepatitis
por: Satapathy, Sanjaya K., et al.
Publicado: (2020)

Luteolin alleviates methionine–choline-deficient diet-induced non-alcoholic steatohepatitis by modulating host serum metabolome and gut microbiome
por: Guo, Wei, et al.
Publicado: (2022)

Changes in the gut microbiome associated with liver stiffness improvement in nonalcoholic steatohepatitis
por: Sharpton, Suzanne R., et al.
Publicado: (2022)

Use of GP73 in the diagnosis of non-alcoholic steatohepatitis and the staging of hepatic fibrosis
por: Li, Yadi, et al.
Publicado: (2021)

Proglumide Reverses Nonalcoholic Steatohepatitis by Interaction with the Farnesoid X Receptor and Altering the Microbiome
por: Gay, Martha D., et al.
Publicado: (2022)

Functional Microbiomics Reveals Alterations of the Gut Microbiome and Host Co‐Metabolism in Patients With Alcoholic Hepatitis
por: Gao, Bei, et al.
Publicado: (2020)

ENO3 promoted the progression of NASH by negatively regulating ferroptosis via elevation of GPX4 expression and lipid accumulation
por: Lu, Di, et al.
Publicado: (2021)

Berberine Alleviates Non-alcoholic Steatohepatitis Through Modulating Gut Microbiota Mediated Intestinal FXR Activation
por: Shu, Xiangbing, et al.
Publicado: (2021)

Gut microbiota contribution to hepatocellular carcinoma manifestation in non-alcoholic steatohepatitis
por: Liakina, Valentina, et al.
Publicado: (2022)

Alterations of Gut Microbiome in the Patients With Severe Fever With Thrombocytopenia Syndrome
por: Xu, Honghai, et al.
Publicado: (2018)

Lack of VMP1 impairs hepatic lipoprotein secretion and promotes non-alcoholic steatohepatitis
por: Jiang, Xiaoxiao, et al.
Publicado: (2022)

(-)-Epigallocatechin-3-gallate suppresses hepatic preneoplastic lesions developed in a novel rat model of non-alcoholic steatohepatitis
por: Sumi, Takafumi, et al.
Publicado: (2013)

Geniposide plus chlorogenic acid reverses non-alcoholic steatohepatitis via regulation of gut microbiota and bile acid signaling in a mouse model in vivo
por: Li, Hongshan, et al.
Publicado: (2023)

Combined alcoholic and non-alcoholic steatohepatitis
por: Ntandja Wandji, Line Carolle, et al.
Publicado: (2020)

Yinzhihuang oral liquid protects against non-alcoholic steatohepatitis via modulation of the gut-liver axis in mice
por: Li, Shuyu, et al.
Publicado: (2022)

Corrigendum: Alterations of Gut Microbiome in the Patients With Severe Fever With Thrombocytopenia Syndrome
por: Xu, Honghai, et al.
Publicado: (2019)

Val‐Val‐Tyr‐Pro protects against non‐alcoholic steatohepatitis in mice by modulating the gut microbiota and gut‐liver axis activation
por: Xie, Xinshu, et al.
Publicado: (2021)

CCN1 promotes hepatic steatosis and inflammation in non-alcoholic steatohepatitis
por: Ju, Linling, et al.
Publicado: (2020)

Modulating hepatic macrophages with annexin A1 in non-alcoholic steatohepatitis
por: De Ponti, Federico F., et al.
Publicado: (2022)

Polychlorinated biphenyls altered gut microbiome in CAR and PXR knockout mice exhibiting toxicant-associated steatohepatitis
por: Wahlang, Banrida, et al.
Publicado: (2021)

Reversal of murine alcoholic steatohepatitis by pepducin-based functional blockade of interleukin-8 receptors
por: Wieser, Verena, et al.
Publicado: (2017)

Lingguizhugan decoction improves non-alcoholic steatohepatitis partially by modulating gut microbiota and correlated metabolites
por: Zhu, Mingzhe, et al.
Publicado: (2023)

Fructose and Non-Alcoholic Steatohepatitis
por: Roeb, Elke, et al.
Publicado: (2021)

Statins in Non-alcoholic Steatohepatitis
por: Torres-Peña, Jose D., et al.
Publicado: (2021)

Characterization of gut microbiome composition in Iranian patients with nonalcoholic fatty liver disease and nonalcoholic steatohepatitis
por: Abdollahiyan, Sara, et al.
Publicado: (2023)

Role of Alcohol Metabolism in Non-Alcoholic Steatohepatitis
por: Baker, Susan S., et al.
Publicado: (2010)

Gut microbiome, metabolome and alopecia areata
por: Liu, Zhiyu, et al.
Publicado: (2023)

Lactiplantibacillus plantarum LPJZ-658 Improves Non-Alcoholic Steatohepatitis by Modulating Bile Acid Metabolism and Gut Microbiota in Mice
por: Liu, Liming, et al.
Publicado: (2023)

Aberrant Hepatic Methionine Metabolism and Gene Methylation in the Pathogenesis and Treatment of Alcoholic Steatohepatitis
por: Halsted, Charles H., et al.
Publicado: (2012)

Amphiregulin activates human hepatic stellate cells and is upregulated in non alcoholic steatohepatitis
por: McKee, Chad, et al.
Publicado: (2015)

Hepatocyte Injury and Hepatic Stem Cell Niche in the Progression of Non-Alcoholic Steatohepatitis
por: Overi, Diletta, et al.
Publicado: (2020)

Hepatic Macrophages as Targets for the MSC-Based Cell Therapy in Non-Alcoholic Steatohepatitis
por: Kholodenko, Irina V., et al.
Publicado: (2023)

Natural products that target macrophages in treating non-alcoholic steatohepatitis
por: Li, Chun-Lin, et al.
Publicado: (2020)

Non-alcoholic Steatohepatitis Pathogenesis, Diagnosis, and Treatment
por: Zhu, Bo, et al.
Publicado: (2021)

Pro‐inflammatory signalling and gut‐liver axis in non‐alcoholic and alcoholic steatohepatitis: Differences and similarities along the path
por: Glaser, Trenton, et al.
Publicado: (2020)

Dual role of protein tyrosine phosphatase 1B in the progression and reversion of non-alcoholic steatohepatitis
por: González-Rodríguez, Águeda, et al.
Publicado: (2017)

Dietary intervention, but not losartan, completely reverses non-alcoholic steatohepatitis in obese and insulin resistant mice
por: Verbeek, Jef, et al.
Publicado: (2017)

P2X7 Receptor in Alcoholic Steatohepatitis and Alcoholic Liver Fibrosis
por: Xia, Guo-Qing, et al.
Publicado: (2022)

Molecular pathogenesis: Connections between viral hepatitis-induced and non-alcoholic steatohepatitis-induced hepatocellular carcinoma
por: Tian, Zelin, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_2l7ad596th9atn44acc5bfh50r